Zafirlukast
Overview
A leukotriene receptor inhibitor, effective in asthma. It is a selective antagonist of leukotriene D 4 recptor, stimulation of which by circulating leukotrienes is thought to play a role in pathogenesis of asthma. It suppresses both early and late bronchoconstrictor responses to inhaled antigens and irritants.
Categories
- 25 Drugs acting on the respiratory tract
- 25.1 Anti-asthmatic drugs
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Zafirlukast's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 20 mg | 20 (20) | 12 hourly | PO | |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Zafirlukast is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Zafirlukast is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Zafirlukast
Back to top
Previous Drug Generic - Next Drug Generic